Those are some of the questions dermatologists face when a patient on systemic therapy for psoriasis does not respond fully, when the patient reacts favorably at first but then treatment effectiveness ...
Systemic therapy is often given late due to optimism bias, treatment momentum, and difficulty in end-of-life conversations, leading to increased hospitalizations and ICU admissions. MD Anderson Cancer ...
NICE has recommended a new treatment option for adults with recurrent or metastatic cervical cancer that has progressed on or ...
Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy This trial randomly ...
Andy Blauvelt, MD, MBA, president of Oregon Medical Research Center, discusses the use of systemic therapies vs biologics and why adherence is so important when treating patients with atopic ...
View all available purchase options and get full access to this article. This Q&A is derived from recommendations in Systemic Therapy for Tumor Control in Metastatic Well-differentiated ...
A urologic oncology fellow provides a comprehensive overview of systemic therapy options for patients with prostate cancer. This is a synopsis of an Educated Patient Sound Bites series featuring ...
Until about 20 years ago, systemic treatment options for moderate/severe psoriasis were limited and nonspecific. To get an idea of how much the field has changed, clinical guidelines on psoriasis ...
Combining golimumab and guselkumab into JNJ-78934804, a fixed-dose co-antibody therapy, helped overcome treatment failure in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results